Nature Communications (Nov 2022)

Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel

  • Joshua Guedalia,
  • Michal Lipschuetz,
  • Ronit Calderon-Margalit,
  • Sarah M. Cohen,
  • Debra Goldman-Wohl,
  • Tali Kaminer,
  • Eli Melul,
  • Galit Shefer,
  • Yishai Sompolinsky,
  • Asnat Walfisch,
  • Simcha Yagel,
  • Ofer Beharier

DOI
https://doi.org/10.1038/s41467-022-34605-x
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 7

Abstract

Read online

Data on the effectiveness of a third dose of COVID-19 vaccine in pregnant women are limited. In this observational study, the authors report that a third dose of the BNT162b2 mRNA COVID-19 vaccine during pregnancy enhances protection against maternal adverse COVID-19-related outcomes.